Spectrum Pharmaceuticals

Spectrum Pharmaceuticals FCF per Share

Delisted

The Free Cash Flow per Share of Spectrum Pharmaceuticals (SPPI) as of Nov 15, 2026 is -0.53 USD. In the previous year, Free Cash Flow per Share was -0.77 USD — a change of -31.41% (higher).

FCF per Share

-0.53USD

YoY

-31.41%

Last updated:

Free Cash Flow per Share of Spectrum Pharmaceuticals is 2022 -0.53 USD. Free Cash Flow per Share of Spectrum Pharmaceuticals was 2021 -0.77 USD. It decreases by -31.41% higher compared to the previous year.

The Spectrum Pharmaceuticals FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2015
0.10 USD
Jan 1, 2016
-0.52 USD
Jan 1, 2017
-0.40 USD
Jan 1, 2018
-0.62 USD
Jan 1, 2019
-1.29 USD
Jan 1, 2020
-0.90 USD
Jan 1, 2021
-0.77 USD
Jan 1, 2022
-0.53 USD
The Spectrum Pharmaceuticals FCF per Share history
YEARFCF per ShareYoY
-0.53USD-31.41%
-0.77USD-13.93%
-0.90USD-30.30%
-1.29USD+109.13%
-0.62USD+54.32%
-0.40USD-22.69%
-0.52USD-618.32%
0.10USD-242.28%
-0.07USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Spectrum Pharmaceuticals Stock analysis

What does Spectrum Pharmaceuticals do? Spectrum Pharmaceuticals Inc. is an American biotechnology company specializing in the development and commercialization of drugs for the treatment of cancer and other serious diseases. It was founded in 1987 and is headquartered in Irvine, California. The company's CEO is Rajesh C. Shrotriya, who has a clear vision of specializing in pharmaceutical development to meet the needs of patients with unmet medical needs. Spectrum Pharmaceuticals has a wide range of products, with a focus on oncology and hematology. It also has a promising drug candidate pipeline. The company works closely with healthcare professionals and regulatory authorities to ensure the highest quality standards are met. Spectrum Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spectrum Pharmaceuticals stock

Free Cash Flow per Share of Spectrum Pharmaceuticals is -0.53 USD in 2022.

Free Cash Flow per Share of Spectrum Pharmaceuticals changed from -0.77 USD to -0.53 USD, representing a -31.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Spectrum Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Spectrum Pharmaceuticals

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Spectrum Pharmaceuticals